MYC and COVID-19: The results indicated that inflammatory response and Il2 stat5 signaling pathways were activated, while oxidative phosphorylation, fatty acid metabolism, and Myc targets V1 pathways were inhibited in the high-expression matrix in the COVID-19-related dataset (Figure 7).